PHR - Phreesia - Stock Price & Dividends
Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US71944F1066
Healthcare Software, Payment Platform, Scheduling, Registration, Revenue Cycle Management
Phreesia Inc, a leading healthcare technology company, offers a comprehensive software and payment platform designed specifically for the healthcare industry in the United States and Canada.
Their innovative solutions cater to various aspects of healthcare management, including appointment scheduling, patient registration, and revenue cycle management. Their appointment scheduling system enables online appointments, reminders, and referral tracking management, streamlining the process for healthcare providers and patients alike.
Their registration solution automates patient self-registration, reducing wait times and improving the overall patient experience. Additionally, their revenue cycle solution provides a range of features, including insurance verification, point-of-sale payments, post-visit payment collection, and flexible payment options, helping healthcare providers to optimize their revenue cycle processes.
Phreesia's network connect solution delivers clinically relevant content to patients, further enhancing their healthcare experience. The company's platform is accessible through various modalities, including Phreesia Mobile, a patient-facing mobile application; Phreesia Dashboard, a web-based dashboard for healthcare providers; PhreesiaPads, self-service intake tablets; and Arrivals Kiosks, on-site kiosks.
Phreesia's solutions are designed to cater to a diverse range of healthcare organizations, including patients, single-specialty practices, multi-specialty groups, and health systems, as well as pharmaceutical, medical device, and biotechnology companies. By providing a comprehensive and integrated platform, Phreesia helps healthcare providers to improve operational efficiency, reduce costs, and enhance patient satisfaction.
Founded in 2005, Phreesia Inc is headquartered in Wilmington, Delaware, and has established itself as a trusted partner for healthcare organizations seeking to leverage technology to improve their operations and patient care. For more information, visit their website at https://www.phreesia.com.
Drawdown (Underwater) Chart
![Drawdown / Underwater Chart for PHR - Phreesia - Stock Price & Dividends](https://www.valueray.com/images/drawdown_chart/PHR.NYSE_drawdown.png)
Overall Trend and Yearly Seasonality
![Drawdown / Underwater Chart for PHR - Phreesia - Stock Price & Dividends](https://www.valueray.com/images/chart/PHR.NYSE_seasonality.png)
PHR Stock Overview
Market Cap in USD | 1,476m |
Sector | Healthcare |
Industry | Health Information Services |
GiC SubIndustry | Health Care Technology |
TER | 0.00% |
IPO / Inception | 2019-07-18 |
PHR Stock Ratings
Growth 5y | -3.70 |
Fundamental | -52.0 |
Dividend | 0.00 |
Rel. Performance vs Sector | -0.37 |
Analysts | 4.53/5 |
Fair Price Momentum | 22.65 USD |
Fair Price DCF | - |
PHR Dividends
Dividend Yield 12m | 0.00% |
Yield on Cost 5y | 0.00% |
Dividends CAGR 5y | 0.00% |
Payout Consistency | 0.0% |
PHR Growth Ratios
Growth 12m | 7.53% |
Growth Correlation 12m | 46% |
Growth Correlation 3m | 81% |
CAGR 5y | 0.91% |
CAGR/Mean DD 5y | 0.02 |
Sharpe Ratio 12m | 0.04 |
Alpha vs SP500 12m | -28.44 |
Beta vs SP500 5y weekly | 1.73 |
ValueRay RSI | 49.94 |
Volatility GJR Garch 1y | 56.60% |
Price / SMA 50 | 1.07% |
Price / SMA 200 | 3.74% |
Current Volume | 486.8k |
Average Volume 20d | 381.6k |
External Links for PHR Stock
Wall Street Journal • Benzinga • Yahoo Finance
Tweets
X • Stocktwits
Fund Manager Positions
Dataroma • Stockcircle
As of September 08, 2024, the stock is trading at USD 23.55 with a total of 486,786 shares traded.
Over the past week, the price has changed by -8.40%, over one month by +3.38%, over three months by +19.24% and over the past year by +7.68%.
According to ValueRays Forecast Model, PHR Phreesia will be worth about 25.7 in September 2025. The stock is currently trading at 23.55. This means that the stock has a potential upside of +8.96%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 29.1 | 23.4 |
Analysts Target Price | 36.1 | 53.2 |
ValueRay Target Price | 25.7 | 8.96 |